Literature DB >> 18052996

Risk factors for early sepsis in very low birth weight neonates with respiratory distress syndrome.

Laliv Shani1, Dahlia Weitzman, Rimma Melamed, Ehud Zmora, Kyla Marks.   

Abstract

AIM: To identify maternal and neonatal factors that increase suspicion of early sepsis in Very Low Birth Weight neonates with respiratory distress syndrome.
METHODS: The cohort included 282 neonates born at Soroka Medical Centre 1996-2000. Definitions of 'high' and 'low'-suspicion groups for early sepsis were based on comparison between neonates with early sepsis and the remaining cohort. Univariate analysis and logistic regression were used to compare between groups.
RESULTS: The incidence of early sepsis in the cohort was 1.8%, and 94% received antibiotics following delivery. Comparing with the remaining cohort, the five neonates with early sepsis had increased incidence of positive maternal cultures, use of antenatal antibiotics, lower 1 min Apgar scores and tendency to leucopenia. A 'low-suspicion' group comprised 38% of the cohort and did not include any neonates with early sepsis. This group were more frequently treated with antenatal steroids and delivered by Caesarean section compared to the 'high-suspicion' group, but otherwise there were no clinical and laboratory differences.
CONCLUSION: Although the incidence of early sepsis is low almost all neonates received antibiotics. A 'low-suspicion' group was defined and the role of antibiotic treatment in this group needs to be determined.

Entities:  

Mesh:

Year:  2007        PMID: 18052996     DOI: 10.1111/j.1651-2227.2007.00571.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  2 in total

1.  Presumed and definite bacteremia in extremely low gestational age newborns.

Authors:  Sonal Patel; Olaf Dammann; Camilia R Martin; Elizabeth N Allred; Alan Leviton
Journal:  Acta Paediatr       Date:  2010-08-16       Impact factor: 2.299

2.  Optimizing the Use of Antibacterial Agents in the Neonatal Period.

Authors:  Joseph B Cantey
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.